title: A complete plasmid-based complementation system for RNA coliphage Q beta: three proteins of bacteriophages Q beta (group III) and SP (group IV) can be interchanged.
abstract: Our laboratory has established a bacteriophage Q beta cDNA-containing plasmid system in which virtually all coding defects present within the 4217 nucleotide Q beta genome can be complemented in trans. In this system, Q beta minus strand RNAs are constitutively transcribed from plasmid cDNA by Escherichia coli RNA polymerase. Replication of these minus strands results in the synthesis of Q beta plus RNA, thereby triggering an infectious cycle in which Q beta phase particles are generated. Genetically engineered Q beta genome mutations that result in defective viral proteins can be complemented in trans by the products of one or more Q beta helper plasmids that express either: (1) Q beta maturation protein, which can complement defects in the Q beta maturation cistron (nucleotides 61 to 1320); (2) Q beta readthrough protein, which can complement defects in the readthrough cistron (nucleotides 1344 to 2330); or (3) Q beta replicase, which can complement defects in the replicase cistron (nucleotides 2352 to 4118). Each plasmid component of this system contains a unique origin of replication and carries a different antibiotic gene, thereby enabling all combinations of these plasmids to coexist in the same host. We have further developed a second series of helper plasmids that generate the corresponding viral proteins of the related group IV RNA phage SP. Each of these SP helper proteins can complement respective defects within the Q beta genome with efficiencies similar to those observed for the Q beta helper proteins. It is now possible to supply functional Q beta or SP proteins in trans to examine Q beta genomes that contain protein coding defects for their ability to synthesize Q beta proteins, replicate Q beta RNA, assemble virions, and/or lyse the host cell.
authors.affiliation: Department of Microbiology and Immunology, State University of New York Health Science Center at Brooklyn 11203, USA.
authors.forename: C
authors.initials: C
authors.lastname: Priano
authors.forename: R
authors.initials: R
authors.lastname: Arora
authors.forename: J
authors.initials: J
authors.lastname: Butke
authors.forename: D R
authors.initials: DR
authors.lastname: Mills
mesh_terms: D017908:Allolevivirus / Q000235:genetics* / Q000378:metabolism; D001483:Base Sequence; D003062:Codon; D017931:DNA Primers; D004926:Escherichia coli / Q000235:genetics* / Q000378:metabolism; D005816:Genetic Complementation Test; D016679:Genome, Viral; D008969:Molecular Sequence Data; D010957:Plasmids; D011777:Q beta Replicase / Q000235:genetics*; D012328:RNA Viruses / Q000235:genetics* / Q000378:metabolism; D015183:Restriction Mapping; D014764:Viral Proteins / Q000096:biosynthesis / Q000235:genetics*
chemical_list: D003062:Codon; D017931:DNA Primers; D014764:Viral Proteins; D011777:Q beta Replicase